{"abstract":"The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pharmacy Compounding Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.","action":"Notice; establishment of a public docket; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/16/2026-07361.html","cfr_references":[],"citation":"91 FR 20465","comment_url":"http://www.regulations.gov/commenton/FDA-2025-N-6895-0001","comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The meeting will be held on July 23, 2026, from 8:00 a.m. to 4:30 p.m. Eastern Time and July 24, 2026, from 8:00 a.m. to 3:50 p.m. Eastern Time.","disposition_notes":null,"docket_ids":["Docket No. FDA-2025-N-6895"],"dockets":[],"document_number":"2026-07361","effective_on":null,"end_page":20467,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/16/2026-07361.xml","html_url":"https://www.federalregister.gov/documents/2026/04/16/2026-07361/pharmacy-compounding-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-07361?publication_date=2026-04-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-16/2026-07361/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":111,"last_updated":"2026-04-16 16:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-16/pdf/2026-07361.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-07361.pdf?1776257113","publication_date":"2026-04-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/16/2026-07361.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2025-N-6895","supporting_documents_count":0,"docket_id":"FDA-2025-N-6895","document_id":"FDA-2025-N-6895-0001","regulation_id_number":null,"title":"Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments--Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List","checked_regulationsdotgov_at":"2026-04-16T18:01:21Z"},"regulations_dot_gov_url":"http://www.regulations.gov/commenton/FDA-2025-N-6895-0001","significant":null,"signing_date":null,"start_page":20465,"subtype":null,"title":"Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List","toc_doc":"Pharmacy Compounding Advisory Committee; Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List","toc_subject":"Hearings, Meetings, Proceedings, etc.","topics":[],"type":"Notice","volume":91}